oncogenic pathway signatures human cancers guide targeted therapies
development oncogenic state complex process involving accumulation multiple independent mutations lead deregulation cell signalling pathways central control cell growth cell fate- ability define cancer subtypes recurrence disease response specific therapies using dna microarray-based gene expression signatures demonstrated multiple studies various studies also demonstrated potential using gene expression profiles analysis oncogenic pathways- show gene expression signatures can identified reflect activation status several oncogenic pathways evaluated several large collections human cancers gene expression signatures identify patterns pathway deregulation tumours clinically relevant associations disease outcomes combining signature-based predictions across several pathways identifies coordinated patterns pathway deregulation distinguish specific cancers tumour subtypes clustering tumours based pathway signatures defines prognosis respective patient subsets demonstrating patterns oncogenic pathway deregulation underlie development oncogenic phenotype reflect biology outcome specific cancers predictions pathway deregulation cancer cell lines also shown predict sensitivity therapeutic agents target components pathway linking pathway deregulation sensitivity therapeutics target components pathway provides opportunity make use oncogenic pathway signatures guide use targeted therapeutics
